Preoperative capecitabine with pelvic radiotherapy for locally advanced rectal cancer (phase I trial)

• Main Authors: Veerasarn V., Phromratanapongse P., Lorvidhaya V., Lertsanguansinchai P., Lertbutsayanukul C., Panichevaluk A., Boonnuch W., Chinswangwatanakul V., Lohsiriwat D., Rojanasakul A., Thavichaigarn P., Jivapaisarnpong P.
• 格式: Article
• 語言: English
• 出版: 2014
• 在線閱讀: http://www.scopus.com/inward/record.url?eid=2-s2.0-33845495420&partnerID=40&md5=31aee1aa06e324d9dc4b8648a1d6bbd4; http://cmuir.cmu.ac.th/handle/6653943832/2017
• 機構: Chiang Mai University

Objective: Phase I multicenter study defined the maximal tolerated dose (MTD), dose-limiting toxicity (DLT) and safety profile of capecitabine in combination with preoperative radiation for patients with locally advanced rectal cancer (LARC). Material and Method: Patients were treated with oral cape...